{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:39:09Z","timestamp":1792557549461,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03314-w","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T02:13:25Z","timestamp":1785118405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic retinopathy enhances coronary artery calcium-based cardiovascular risk stratification in patients with type 2 diabetes: insights from the ACCoDiab study"],"prefix":"10.1186","volume":"25","author":[{"given":"Franck","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Andreelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Broussaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Boussouar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Caroline","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Toulgoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bourron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Redheuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"9435","key":"3314_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736","volume":"364","author":"HM Colhoun","year":"2004","unstructured":"Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685\u201396. https:\/\/doi.org\/10.1016\/S0140-6736.","journal-title":"Lancet"},{"issue":"9500","key":"3314_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736","volume":"366","author":"A Keech","year":"2005","unstructured":"Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366(9500):1849\u201361. https:\/\/doi.org\/10.1016\/S0140-6736.","journal-title":"Lancet"},{"issue":"24","key":"3314_CR3","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372. https:\/\/doi.org\/10.1056\/NEJMoa0802987.","journal-title":"N Engl J Med"},{"issue":"24","key":"3314_CR4","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359. https:\/\/doi.org\/10.1056\/NEJMoa0802743.","journal-title":"N Engl J Med"},{"key":"3314_CR5","doi-asserted-by":"publisher","unstructured":"BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503\u201315. https:\/\/doi.org\/10.1056\/NEJMoa0805796.","DOI":"10.1056\/NEJMoa0805796"},{"issue":"15","key":"3314_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2009.476","volume":"301","author":"LH Young","year":"2009","unstructured":"Young LH, Wackers FJT, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547\u201355. https:\/\/doi.org\/10.1001\/jama.2009.476.","journal-title":"JAMA"},{"issue":"18","key":"3314_CR7","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/eurheartj\/ehn279","volume":"29","author":"RS Elkeles","year":"2008","unstructured":"Elkeles RS, Godsland IF, Feher MD, Rubens MB, Roughton M, Nugara F, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J. 2008;29(18):2244\u201351. https:\/\/doi.org\/10.1093\/eurheartj\/ehn279.","journal-title":"Eur Heart J sept"},{"issue":"4","key":"3314_CR8","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2337\/dc12-1548","volume":"36","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Cox AJ, Herrington DM, Jorgensen NW, Xu J, Freedman BI, et al. Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care. 2013;36(4):972\u20137. https:\/\/doi.org\/10.2337\/dc12-1548.","journal-title":"Diabetes Care"},{"issue":"12","key":"3314_CR9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","volume":"2","author":"S Malik","year":"2017","unstructured":"Malik S, Zhao Y, Budoff M, Nasir K, Blumenthal RS, Bertoni AG, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis. JAMA Cardiol. 2017;2(12):1332\u201340. https:\/\/doi.org\/10.1001\/jamacardio.2017.4191.","journal-title":"JAMA Cardiol"},{"key":"3314_CR10","doi-asserted-by":"publisher","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323. https:\/\/doi.org\/10.1093\/eurheartj\/ehz486.","DOI":"10.1093\/eurheartj\/ehz486"},{"issue":"1","key":"3314_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-020-01192-4","volume":"20","author":"K Ichikawa","year":"2021","unstructured":"Ichikawa K, Miyoshi T, Osawa K, Miki T, Toda H, Ejiri K, et al. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):8. https:\/\/doi.org\/10.1186\/s12933-020-01192-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"25","key":"3314_CR12","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy","volume":"39","author":"MJ Budoff","year":"2018","unstructured":"Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39(25):2401\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehy.","journal-title":"Eur Heart J"},{"key":"3314_CR13","doi-asserted-by":"publisher","unstructured":"Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336\u201345. https:\/\/doi.org\/10.1056\/NEJMoa072100.","DOI":"10.1056\/NEJMoa072100"},{"issue":"6","key":"3314_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.diabet.2019.04.002","volume":"45","author":"F Semeraro","year":"2019","unstructured":"Semeraro F, Morescalchi F, Cancarini A, Russo A, Rezzola S, Costagliola C. Diabetic retinopathy, a vascular and inflammatory disease: therapeutic implications. Diabetes Metab. 2019;45(6):517\u201327. https:\/\/doi.org\/10.1016\/j.diabet.2019.04.002.","journal-title":"Diabetes Metab"},{"key":"3314_CR15","doi-asserted-by":"publisher","unstructured":"Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan-Giri A, Vickery T, et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. In: Proceedings of the National Academy of Sciences; 2012, pp. E715\u2013724. https:\/\/doi.org\/10.1073\/pnas.1111600109.","DOI":"10.1073\/pnas.1111600109"},{"issue":"6917","key":"3314_CR16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374. https:\/\/doi.org\/10.1038\/nature01323.","journal-title":"Nature"},{"key":"3314_CR17","doi-asserted-by":"publisher","unstructured":"Betteridge DJ. What is oxidative stress? Metabolism. 2000;49(2 Suppl 1):3\u20138. https:\/\/doi.org\/10.1016\/s0026-0495(00)80077-3.","DOI":"10.1016\/s0026-0495(00)80077-3"},{"issue":"1","key":"3314_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00125-017","volume":"61","author":"HP Hammes","year":"2018","unstructured":"Hammes HP. Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia. 2018;61(1):29\u201338. https:\/\/doi.org\/10.1007\/s00125-017-.","journal-title":"Diabetologia"},{"issue":"9","key":"3314_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058\u201370. 10.1161. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223545.","journal-title":"Circ Res"},{"issue":"8","key":"3314_CR20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","volume":"25","author":"T M\u00fcnzel","year":"2005","unstructured":"M\u00fcnzel T, Daiber A, Ullrich V, M\u00fclsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005;25(8):1551\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"3314_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2337\/dc07","volume":"31","author":"PD Reaven","year":"2008","unstructured":"Reaven PD, Emanuele N, Moritz T, Klein R, Davis M, Glander K, et al. Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2008;31(5):952\u20137. https:\/\/doi.org\/10.2337\/dc07-1926.","journal-title":"Diabetes Care"},{"issue":"1","key":"3314_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1464-5491.2007.02327.x","volume":"25","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med. 2008;25(1):45\u201350. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02327.x.","journal-title":"Diabet Med"},{"issue":"10","key":"3314_CR23","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.amjcard.2009.01.345","volume":"103","author":"JA Gimeno-Orna","year":"2009","unstructured":"Gimeno-Orna JA, Faure-Nogueras E, Castro-Alonso FJ, Boned-Juliani B. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus. Am J Cardiol. 2009;103(10):1364\u20137. https:\/\/doi.org\/10.1016\/j.amjcard.2009.01.345.","journal-title":"Am J Cardiol"},{"issue":"3","key":"3314_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ophtha.2012.08.029","volume":"120","author":"R Kawasaki","year":"2013","unstructured":"Kawasaki R, Tanaka S, Tanaka S, Abe S, Sone H, Yokote K, et al. Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan diabetes complications study. Ophthalmology. 2013;120(3):574\u201382.","journal-title":"Ophthalmology"},{"issue":"5","key":"3314_CR25","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2337\/dc12-1311","volume":"36","author":"HC Gerstein","year":"2013","unstructured":"Gerstein HC, Ambrosius WT, Danis R, Ismail-Beigi F, Cushman W, Calles J, et al. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care. 2013;36(5):1266\u201371. https:\/\/doi.org\/10.2337\/dc12-1311.","journal-title":"Diabetes Care"},{"key":"3314_CR26","doi-asserted-by":"publisher","unstructured":"Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, Wong TY. Is diabetic retinopathy an independent risk factor for ischemic stroke?. Stroke. 2007;38(2):398\u2013401. https:\/\/doi.org\/10.1161\/01.STR.0000254547.91276.50.","DOI":"10.1161\/01.STR.0000254547.91276.50"},{"issue":"1","key":"3314_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.293.1.63","volume":"293","author":"TY Wong","year":"2005","unstructured":"Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, et al. Retinopathy and risk of congestive heart failure. JAMA. 2005;293(1):63\u20139. https:\/\/doi.org\/10.1001\/jama.293.1.63.","journal-title":"JAMA"},{"issue":"16","key":"3314_CR28","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jacc.2007.11.076","volume":"51","author":"N Cheung","year":"2008","unstructured":"Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR, et al. Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol. 2008;51(16):1573\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2007.11.076.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3314_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-016-0446-x","volume":"15","author":"K Mohammedi","year":"2016","unstructured":"Mohammedi K, Woodward M, Hirakawa Y, Zoungas S, Colagiuri S, Hamet P, et al. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol. 2016;15(1):129. https:\/\/doi.org\/10.1186\/s12933-016-0446-x","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3314_CR30","doi-asserted-by":"publisher","first-page":"e0122022","DOI":"10.1371\/journal.pone.0122022","volume":"10","author":"YW Chen","year":"2015","unstructured":"Chen YW, Wang YY, Zhao D, Yu CG, Xin Z, Cao X, et al. High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy. PLoS ONE. 2015;10(3):e0122022. https:\/\/doi.org\/10.1371\/journal.pone.0122022.","journal-title":"PLoS ONE"},{"issue":"7","key":"3314_CR31","doi-asserted-by":"publisher","first-page":"e0134718","DOI":"10.1371\/journal.pone.0134718","volume":"10","author":"SC Chen","year":"2015","unstructured":"Chen SC, Hsiao PJ, Huang JC, Lin KD, Hsu WH, Lee YL, et al. Abnormally low or high ankle-brachial index is associated with proliferative diabetic retinopathy in type 2 diabetic mellitus patients. PLoS ONE. 2015;10(7):e0134718. https:\/\/doi.org\/10.1371\/journal.pone.0134718 .","journal-title":"PLoS ONE"},{"issue":"2","key":"3314_CR32","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.diabet.2020.08.002","volume":"47","author":"P Valensi","year":"2021","unstructured":"Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, et al. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: position paper of the french society of cardiology and the french-speaking society of diabetology. Diabetes Metab. 2021;47(2):101185. https:\/\/doi.org\/10.1016\/j.diabet.2020.08.002.","journal-title":"Diabetes Metab"},{"key":"3314_CR33","doi-asserted-by":"publisher","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;14(39):4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad.","DOI":"10.1093\/eurheartj\/ehad"},{"key":"3314_CR34","doi-asserted-by":"publisher","unstructured":"Yang JM, Yang DH, Lee SW, Kwak J, Lee Y, Kim YJ et al. Subclinical coronary atherosclerosis and retinal optical coherence tomography angiography. JAMA Cardiol . 2025. https:\/\/doi.org\/10.1001\/jamacardio.2025.3036.","DOI":"10.1001\/jamacardio.2025.3036"},{"key":"3314_CR35","doi-asserted-by":"publisher","unstructured":"Sharma K, Al Rifai M, Ahmed HM, Dardari Z, Silverman MG, Yeboah J, et al. Usefulness of coronary artery calcium to predict heart failure with preserved ejection fraction in men versus women (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2017;15(10):1847\u201353. https:\/\/doi.org\/10.1016\/j.amjcard.2017.07.089.","DOI":"10.1016\/j.amjcard.2017.07.089"},{"issue":"1","key":"3314_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-017-0566-y","volume":"16","author":"YR Chung","year":"2017","unstructured":"Chung YR, Park SJ, Moon KY, Choi SA, Lim HS, Park SW, et al. Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy. Cardiovasc Diabetol. 2017;16(1):82. https:\/\/doi.org\/10.1186\/s12933-017-0566-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3314_CR37","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.2337\/diacare.27.8.1962","volume":"27","author":"M Rema","year":"2004","unstructured":"Rema M, Mohan V, Deepa R, Ravikumar R, Chennai Urban Rural Epidemiology Study-2. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care. 2004;27(8):1962\u20137. https:\/\/doi.org\/10.2337\/diacare.27.8.1962.","journal-title":"Diabetes Care"},{"issue":"12","key":"3314_CR38","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1365-2362.2008.02051x","volume":"38","author":"MT Malecki","year":"2008","unstructured":"Malecki MT, Osmenda G, Walus-Miarka M, Skupien J, Cyganek K, Mirkiewicz-Sieradzka B, et al. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. Eur J Clin Invest d\u00e9c. 2008;38(12):925\u201330. https:\/\/doi.org\/10.1111\/j.1365-2362.2008.02051x.","journal-title":"Eur J Clin Invest d\u00e9c"},{"key":"3314_CR39","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2147\/DMSO.S363406","volume":"15","author":"M Eid","year":"2022","unstructured":"Eid M, Mounir A, El Etriby S, Al Taher A, Ezzat MAW. Diabetic retinopathy as a predictor of angiographic coronary atherosclerosis severity in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;15:1485\u201394. https:\/\/doi.org\/10.2147\/DMSO.S363406.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"3314_CR40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0161-6420(03)00084-8","volume":"110","author":"TY Wong","year":"2003","unstructured":"Wong TY, Klein R, Nieto FJ, Klein BEK, Sharrett AR, Meuer SM, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology. 2003;110(5):933\u201340. https:\/\/doi.org\/10.1016\/S0161-6420(03)00084-8.","journal-title":"Ophthalmology"},{"key":"3314_CR41","doi-asserted-by":"publisher","first-page":"945245","DOI":"10.3389\/fmed.2022.945245","volume":"9","author":"J Barrot","year":"2022","unstructured":"Barrot J, Real J, Vlacho B, Romero-Aroca P, Sim\u00f3 R, Mauricio D, et al. Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes. Front Med (Lausanne). 2022;9:945245. https:\/\/doi.org\/10.3389\/fmed.2022.945245 .","journal-title":"Front Med (Lausanne)"},{"issue":"7533","key":"3314_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","volume":"332","author":"R Huxley","year":"2006","unstructured":"Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73\u20138. https:\/\/doi.org\/10.1136\/bmj.38678.389583.7C.","journal-title":"BMJ"},{"issue":"2","key":"3314_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/dc06-1747","volume":"30","author":"A Juutilainen","year":"2007","unstructured":"Juutilainen A, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care. 2007;30(2):292\u20139. https:\/\/doi.org\/10.2337\/dc06-1747.","journal-title":"Diabetes Care"},{"key":"3314_CR44","doi-asserted-by":"publisher","unstructured":"Valero-Ochando J, Cant\u00f3 A, L\u00f3pez-Pedrajas R, Almansa I, Miranda M. Role of gonadal steroid hormones in the eye: therapeutic implications. Biomolecules. 2024;7(10):1262. https:\/\/doi.org\/10.3390\/biom14101262.","DOI":"10.3390\/biom14101262"},{"key":"3314_CR45","doi-asserted-by":"publisher","first-page":"5539383","DOI":"10.1155\/joph\/5539383","volume":"2026","author":"Z Huang","year":"2026","unstructured":"Huang Z, Wei J, Yang D. Recent investigations on pathogenesis, biomarkers, epigenetics, and emerging therapeutic strategies to modulate multiple signaling pathways in diabetic retinopathy. J Ophthalmol. 2026;2026:5539383. https:\/\/doi.org\/10.1155\/joph\/5539383.","journal-title":"J Ophthalmol"},{"key":"3314_CR46","doi-asserted-by":"crossref","unstructured":"Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43(9):1663\u20139.","DOI":"10.1016\/j.jacc.2003.09.068"},{"issue":"1","key":"3314_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12933-017-0574-y","volume":"16","author":"K Mohammedi","year":"2017","unstructured":"Mohammedi K, Woodward M, Marre M, Colagiuri S, Cooper M, Harrap S, et al. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):95. https:\/\/doi.org\/10.1186\/s12933-017-0574-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"3314_CR48","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","volume":"145","author":"JJ Joseph","year":"2022","unstructured":"Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the american heart association. Circulation. 2022;145(9):e722\u201359. https:\/\/doi.org\/10.1161\/CIR.0000000000001040","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03314-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:48:08Z","timestamp":1792554488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03314-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3314"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03314-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee (PARIS VI CPP) and registered in ClinicalTrials.gov (Identifiers: NCT03920683). All patients were informed about the study objectives and procedure. Participants gave their written informed consent to participate prior to inclusion.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"309"}}